


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:02:58Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12407813" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12407813</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-id journal-id-type="pmc-domain-id">3848</journal-id><journal-id journal-id-type="pmc-domain">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title-group><journal-title>bioRxiv</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn><publisher><publisher-name>Cold Spring Harbor Laboratory Preprints</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12407813</article-id><article-id pub-id-type="pmcid-ver">PMC12407813.1</article-id><article-id pub-id-type="pmcaid">12407813</article-id><article-id pub-id-type="pmcaiid">12407813</article-id><article-id pub-id-type="pmid">40909513</article-id><article-id pub-id-type="doi">10.1101/2025.08.25.672235</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>
Phenotypic screening converges on CDK9 inhibition as a therapeutic strategy in translocation renal cell carcinoma
</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Thapa</surname><given-names initials="DR">Dharma R.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Deodhar</surname><given-names initials="R">Riva</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Skepner</surname><given-names initials="A">Adam</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Konda</surname><given-names initials="P">Prathyusha</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="M">Meng</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bluck</surname><given-names initials="J">Joseph</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pichlo</surname><given-names initials="C">Christian</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cui</surname><given-names initials="Y">Yantong</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stocker</surname><given-names initials="P">Paige</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khanna</surname><given-names initials="P">Prateek</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="J">Jiao</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tsai</surname><given-names initials="JM">Jonathan M.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leed</surname><given-names initials="A">Alison</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gould</surname><given-names initials="S">Sandy</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alimova</surname><given-names initials="M">Maria</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Friedrich</surname><given-names initials="D">Dhana</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cheah</surname><given-names initials="JH">Jaime H.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rupaimoole</surname><given-names initials="R">Rajesha</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guicherit</surname><given-names initials="O">Oivin</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Viswanathan</surname><given-names initials="SR">Srinivas R.</given-names></name></contrib></contrib-group><pub-date pub-type="epub"><day>30</day><month>8</month><year>2025</year></pub-date><issue-id pub-id-type="pmc-issue-id">496186</issue-id><elocation-id>2025.08.25.672235</elocation-id><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-05 09:25:55.133"><day>05</day><month>09</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License</ext-link>, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="nihpp-2025.08.25.672235v1.pdf"/><self-uri xlink:href="http://biorxiv.org/lookup/doi/10.1101/2025.08.25.672235">http://biorxiv.org/lookup/doi/10.1101/2025.08.25.672235</self-uri><self-uri content-type="pdf">nihpp-2025.08.25.672235.pdf</self-uri><abstract><title>Abstract</title><p>
Translocation renal cell carcinoma (tRCC) is an aggressive kidney cancer driven by gene fusions of the
<italic toggle="yes">TFE3</italic>
transcription factor.
<italic toggle="yes">TFE3</italic>
is essential in tRCC but dispensable in normal cells, presenting an attractive but pharmacologically challenging therapeutic target. We show that the basic helix-loop-helix (bHLH) domain of TFE3 is crucial for chromatin binding and transcriptional function. Via a phenotypic screen of 25,000 compounds, we identified molecules that either displace or retain chromatin-bound TFE3. BRD6866, a compound trapping TFE3 on chromatin, emerged as a pan-CDK inhibitor. Mechanistically, its inhibition of CDK9 &#8211; a key regulator of transcriptional elongation &#8211; was linked to impaired TFE3 fusion activity. These effects were recapitulated by the CDK9-selective inhibitor enitociclib, which downregulated TFE3 targets and suppressed tRCC cell growth. Our findings nominate CDK9 inhibition as a therapeutic strategy in tRCC and demonstrate the utility of mechanism-informed phenotypic screening for challenging targets.
</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>